Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04229693
Other study ID # UHC_NAMU
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 7, 2020
Est. completion date August 2021

Study information

Verified date February 2020
Source University Hospital of Cologne
Contact Titus Keller, MD
Phone 0049 221 4449
Email titus.keller@uk-koeln.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Investigation of the cerebrospinal fluid proteom in preterm infants with posthemorrhagic hydrocephalus in our neonatology center with analysis for modulation of proteom in dependence of breastmilk feeding and way of application such as via gavage tube, oral or nasal application.


Description:

Since the nasal route might be highly effective for neurotrophins and other growth factors the cerebrospinal fluid will be investigated using mass spectrometry to identify modulating effects of intranasal breast milk application on the cerebrospinal fluid proteom.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date August 2021
Est. primary completion date February 2021
Accepts healthy volunteers No
Gender All
Age group N/A to 12 Months
Eligibility Inclusion Criteria:

- preterm infant with hydrocephalus and regular drainage

Exclusion Criteria:

- Inborn error of metabolism

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
no intervention, only observational.

Locations

Country Name City State
Germany Neonatology at the University Hospital of Cologne Cologne

Sponsors (1)

Lead Sponsor Collaborator
University Hospital of Cologne

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Keller T, Körber F, Oberthuer A, Schafmeyer L, Mehler K, Kuhr K, Kribs A. Intranasal breast milk for premature infants with severe intraventricular hemorrhage-an observation. Eur J Pediatr. 2019 Feb;178(2):199-206. doi: 10.1007/s00431-018-3279-7. Epub 2018 Nov 1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Cerebrospinal fluid proteom Cerebrospinal fluid analysis using mass spectrometry including proteomic analysis for differences in dependence of intranasal breast milk application weeks
See also
  Status Clinical Trial Phase
Completed NCT05762848 - Clinical Application and Functionality for an Application for Measurement of Head Circumference.
Not yet recruiting NCT06310213 - Non-Invasive Pressure Monitor for Neonates & Infants at Risk of Developing Hydrocephalus N/A